PROCEPT BioRobotics Q2 revenue $33.1M (+98% YoY); raises FY2023 guidance to $131M

PROCEPT BioRobotics Corp

2023-Q2 EPS reported -$1.19 revenue$57,508,000

Record 40 U.S. AquaBeam systems sold in Q2; U.S. system revenue $14.8M (+74% YoY).
U.S. handpiece & consumables revenue $13.6M (+138% YoY); utilization per account up 9%.
Gross margin 56% (vs 51% prior year); narrowed net loss $25.3M vs $19.2M.
FY2023 revenue guidance raised to $131M (from $128M); gross margin ~55% (from ~54%).
United Healthcare issued positive coverage policy for Aquablation, effective June 1, 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

PROCEPT BioRobotics Corp reported quarter ended June 30, 2023 results: net income -$25.3 million.

Period: quarter ended June 30, 2023
Net income: -$25.3 million
Result: reported results

Exact text from the filing

Total revenue for the second quarter of 2023 was $33.1 million, an increase of 98% compared to the prior year period.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

PROCEPT BioRobotics Corp reported quarter ended June 30, 2023 results: net income -$25.3 million.

Period: quarter ended June 30, 2023
Net income: -$25.3 million
Result: reported results

Exact text from the filing

Net loss was $25.3 million for the second quarter of 2023, compared to a loss of $19.2 million in the prior year period.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

PROCEPT BioRobotics Corp reported full year 2023 results: revenue $131 million. Guidance raised.

Period: full year 2023
Revenue: $131 million
Guidance: raised
Result: guidance update

Exact text from the filing

The Company projects revenue for the full year 2023 to be approximately $131 million, which represents 75% growth over the Company’s prior year revenue. This compares to previous revenue guidance of $128 million.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

PROCEPT BioRobotics Corp filing history →

Source: SEC EDGAR

accession 0001588978-23-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.